about
sameAs
Mitoxantrone for multiple sclerosisA novel data mining system points out hidden relationships between immunological markers in multiple sclerosis.Comparative efficacy of interferon β versus glatiramer acetate for relapsing-remitting multiple sclerosis.Drug therapy for multiple sclerosis.T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.MicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progressionIndoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis.A semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation proceduresMultimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal studyInterferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.A telemedicine meditation intervention for people with multiple sclerosis and their caregivers: study protocol for a randomized controlled trialB Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity.Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticityGrowth hormone and disease severity in early stage of multiple sclerosis.MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype.Are Modular Activations Altered in Lower Limb Muscles of Persons with Multiple Sclerosis during Walking? Evidence from Muscle Synergies and Biomechanical AnalysisSativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).Atlas-based vs. individual-based deterministic tractography of corpus callosum in multiple sclerosis.Determinants of disability in multiple sclerosis: an immunological and MRI study.A role for the TIM-3/GAL-9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis.Multidisciplinary Rehabilitation is Efficacious and Induces Neural Plasticity in Multiple Sclerosis even when Complicated by Progressive Multifocal Leukoencephalopathy.Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes.Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study.Predictors of effectiveness of multidisciplinary rehabilitation treatment on motor dysfunction in multiple sclerosis.Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: a longitudinal study.Toll-like receptor 3 differently modulates inflammation in progressive or benign multiple sclerosis.In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.Prediction of Falls in Subjects Suffering From Parkinson Disease, Multiple Sclerosis, and Stroke.Long-term disability progression in primary progressive multiple sclerosis: a 15-year study.Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis.Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.Corticospinal tract integrity is related to primary motor cortex thinning in relapsing-remitting multiple sclerosis.Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.A diffusion tensor MRI study of cervical cord damage in benign and secondary progressive multiple sclerosis patients.A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.White Matter Tract Injury is Associated with Deep Gray Matter Iron Deposition in Multiple Sclerosis.Indoleamine-2,3-dioxygenase(IDO)2 polymorphisms are not associated with multiple sclerosis in Italians.Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.Effects of motor rehabilitation on mobility and brain plasticity in multiple sclerosis: a structural and functional MRI study.Online meditation training for people with multiple sclerosis: A randomized controlled trial.
P50
Q24202866-FFB15212-BEBB-4F1F-8E51-0F094657B975Q30585550-C1DD4DE2-FFB7-402D-A342-9ADF569BE689Q30882362-694621EC-2102-4CD5-BB5A-E47B81E64092Q33990246-803E89F3-7D28-42E7-95C8-F9481FB6783AQ34410090-FD1C8E13-F787-4BD2-AFD0-A5631E467785Q35599410-1E411917-D8B5-478D-AD32-3F84C20B829EQ35674541-C02FCD5A-840A-496B-BA55-8AD9BB8F44F8Q35893074-ABCE3B70-FC40-4075-80E9-E37690CED698Q36143122-DA1FAF5E-1855-4BD8-80CD-D5BB5C897A96Q36202727-09C71E17-EED7-4E06-AAAE-39C37EB25004Q36428507-3263048A-1017-4405-A6C8-8DF21C9EA8BFQ37093281-136CB96B-1C0D-4DB0-99AC-2B829C4E8B81Q37235845-E7908DA8-883C-47A8-B738-B9B0016D1590Q37292163-703147FC-18D4-4976-BBA2-0F795044F831Q37477902-1A954C8E-6A91-4083-B1B8-94E7D621F53CQ37486630-BA41A82E-73A4-4701-BF7D-1CC292C703AAQ38649249-597F7DFA-7243-4EB0-BDDC-A1CF31BE6D07Q39922370-330FFCF1-9778-425A-B7DA-60F65F9D5FBCQ41129964-27035BD6-0CDB-4D47-B76F-530CB665853FQ42202026-677EECC5-2D98-4A9A-A31D-A17778505EA3Q42363059-5DC6B9E2-CCA9-4A22-9573-E52A2394422BQ43041877-E2317B71-4C4B-4F45-AC58-7DC8F32ACBEDQ44642567-7B035C88-BA74-4200-8193-5D040078E23BQ44765850-C9D0680E-5899-472C-A282-76E59189C3E3Q44869530-23A5F5C7-BE4C-48F5-AAA0-D45A4D3C20FDQ44918855-BCCA4925-13B6-43D9-84A4-436C10ED16E4Q45998746-AC58159C-414C-464F-9F3D-0282A4113BE4Q47627933-84F38731-5ECC-45AB-8541-A22542ADEC61Q48009677-BBB0CD43-526A-4EA9-A5F5-82BBE658C64DQ48177354-7679BB61-A224-43E1-A1AD-BD1C54F76222Q48192097-5A856EBE-5D52-464F-8A7D-FBED44EF5D9BQ48271682-485883A1-9691-429D-9619-92A1681E19DEQ48384914-81CF8D88-F7AB-4538-AC1A-E7DE21FFDBD2Q48558386-E084F5D6-3697-455D-A04C-C351FB7A047CQ48620222-E677CBF0-6547-4589-81E7-A4DD77550ACCQ48707884-6DF98B04-5F59-4FEF-BE8F-F39067C41E7EQ50668877-0DE210CD-C54D-4B45-A96F-AB1F1959941CQ50764775-52A8BE13-643E-409D-A261-560DE6866587Q52600253-84E44E52-68D4-4889-ACB5-28A7EAB58826Q52683474-0A9210A8-8E5D-4BF4-A6A9-E2E12958D019
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Marco Rovaris
@en
Marco Rovaris
@nl
type
label
Marco Rovaris
@en
Marco Rovaris
@nl
altLabel
M Rovaris
@en
prefLabel
Marco Rovaris
@en
Marco Rovaris
@nl
P31
P496
0000-0001-9691-1957